Tocilizumab for severe COVID-19 related illness – A community academic medical center experience

Tocilizumab for severe COVID-19 related illness – A community academic medical center experience

The SARS-CoV-2 virus responsible for the COVID-19 pandemic can result in severe or fatal disease in a subset of infected patients. While the pathogenesis of severe COVID-19 disease has yet to be fully elucidated, an overexuberant and harmful immune response to the SARS-CoV-2 virus may be a pivotal a...

Full description

Bibliographic Details
Main Authors: Kapil S Meleveedu, John Miskovsky, Joseph Meharg, Abd Abdelrahman, Richa Tandon, Ashley E. Moody, Priscilla Dasilva, Gabrielle Masse, Jason LaPorte, Abdul Saied Calvino, Greg Allen, Rabih El-Bizri, Todd Roberts, Vincent Armenio, Steven C. Katz
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Cytokine: X
Subjects:
Infectious disease
SARS-CoV-2
IL-6
C-reactive protein
Online Access:http://www.sciencedirect.com/science/article/pii/S259015322030015X

Internet

http://www.sciencedirect.com/science/article/pii/S259015322030015X

Similar Items